172 related articles for article (PubMed ID: 30693087)
1. Combined antitumoral effects of pretubulysin and methotrexate.
Kern S; Truebenbach I; Höhn M; Gorges J; Kazmaier U; Zahler S; Vollmar AM; Wagner E
Pharmacol Res Perspect; 2019 Feb; 7(1):e00460. PubMed ID: 30693087
[TBL] [Abstract][Full Text] [Related]
2. Combination Chemotherapy of L1210 Tumors in Mice with Pretubulysin and Methotrexate Lipo-Oligomer Nanoparticles.
Truebenbach I; Kern S; Loy DM; Höhn M; Gorges J; Kazmaier U; Wagner E
Mol Pharm; 2019 Jun; 16(6):2405-2417. PubMed ID: 31025870
[TBL] [Abstract][Full Text] [Related]
3. Sequence-Defined Oligoamide Drug Conjugates of Pretubulysin and Methotrexate for Folate Receptor Targeted Cancer Therapy.
Truebenbach I; Gorges J; Kuhn J; Kern S; Baratti E; Kazmaier U; Wagner E; Lächelt U
Macromol Biosci; 2017 Oct; 17(10):. PubMed ID: 28371444
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate cytotoxicity as related to irreversible S phase arrest in mouse L1210 leukemia cells.
Tsurusawa M; Niwa M; Katano N; Fujimoto T
Jpn J Cancer Res; 1990 Jan; 81(1):85-90. PubMed ID: 2108951
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric analysis by bromodeoxyuridine/DNA assay of cell cycle perturbation of methotrexate-treated mouse L1210 leukemia cells.
Tsurusawa M; Niwa M; Katano N; Fujimoto T
Cancer Res; 1988 Aug; 48(15):4288-93. PubMed ID: 3390825
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
Wosikowski K; Biedermann E; Rattel B; Breiter N; Jank P; Löser R; Jansen G; Peters GJ
Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750
[TBL] [Abstract][Full Text] [Related]
8. Some biochemical characteristics of L1210 cell lines resistant to 6-mercaptopurine and 6-thioguanine and with increased sensitivity to methotrexate.
Strobel-Stevens JD; El Dareer SM; Trader MW; Hill DL
Biochem Pharmacol; 1982 Oct; 31(19):3133-7. PubMed ID: 6890814
[TBL] [Abstract][Full Text] [Related]
9. Investigations on the mechanisms of methotrexate resistance in a cisplatin-resistant L1210 murine leukemia cell subline.
Wroblewski DH; Bhushan A; Xuan Y; Brinton BT; Tritton TR; Hacker MP
Cancer Chemother Pharmacol; 1996; 37(4):337-42. PubMed ID: 8548879
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate analogues. 34. Replacement of the glutamate moiety in methotrexate and aminopterin by long-chain 2-aminoalkanedioic acids.
Rosowsky A; Bader H; Kohler W; Freisheim JH; Moran RG
J Med Chem; 1988 Jul; 31(7):1338-44. PubMed ID: 2898531
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate analogues. 30. Dihydrofolate reductase inhibition and in vitro tumor cell growth inhibition by N epsilon-(haloacetyl)-L-lysine and N delta-(haloacetyl)-L-ornithine analogues and an acivicin analogue of methotrexate.
Rosowsky A; Solan VC; Forsch RA; Delcamp TJ; Baccanari DP; Freisheim JH
J Med Chem; 1987 Aug; 30(8):1463-9. PubMed ID: 3112397
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antitumor activity of combined methotrexate and histone deacetylase inhibitor valproic acid on mammary cancer in vitro and in vivo.
El Said HH; Badary OA; Shouman SA; Elmazar MM; El-Khatib AS
Can J Physiol Pharmacol; 2022 Sep; 100(9):915-925. PubMed ID: 35679619
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation of HSC70 and its interaction with RFC mediates methotrexate resistance in murine L1210 leukemia cells.
Liu T; Singh R; Rios Z; Bhushan A; Li M; Sheridan PP; Bearden SE; Lai JCK; Agbenowu S; Cao S; Daniels CK
Cancer Lett; 2015 Feb; 357(1):231-241. PubMed ID: 25444929
[TBL] [Abstract][Full Text] [Related]
14. Combined Treatment of MCF-7 Cells with AICAR and Methotrexate, Arrests Cell Cycle and Reverses Warburg Metabolism through AMP-Activated Protein Kinase (AMPK) and FOXO1.
Fodor T; Szántó M; Abdul-Rahman O; Nagy L; Dér Á; Kiss B; Bai P
PLoS One; 2016; 11(2):e0150232. PubMed ID: 26919657
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma.
Lee DH; Thoennissen NH; Goff C; Iwanski GB; Forscher C; Doan NB; Said JW; Koeffler HP
Cancer Lett; 2011 Jul; 306(2):161-170. PubMed ID: 21440986
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cytotoxicity with methotrexate in conjunction with hypoxanthine in L1210 cells in culture.
Fairchild CR; Maybaum J; Straw JA
Cancer Chemother Pharmacol; 1988; 22(1):26-32. PubMed ID: 3396144
[TBL] [Abstract][Full Text] [Related]
17. Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy.
Eleff M; Franks PE; Wampler GL; Collins JM; Goldman ID
Cancer Treat Rep; 1985; 69(7-8):867-74. PubMed ID: 2410122
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate analogues. 25. Chemical and biological studies on the gamma-tert-butyl esters of methotrexate and aminopterin.
Rosowsky A; Freisheim JH; Bader H; Forsch RA; Susten SS; Cucchi CA; Frei E
J Med Chem; 1985 May; 28(5):660-7. PubMed ID: 3872941
[TBL] [Abstract][Full Text] [Related]
19. Lack of therapeutic synergism between vincristine and methotrexate in L1210 murine leukemia in vivo.
Bender RA; Nichols AP; Norton L; Simon RM
Cancer Treat Rep; 1978 Jul; 62(7):997-1003. PubMed ID: 688252
[TBL] [Abstract][Full Text] [Related]
20. Reversal of methotrexate inhibition of colony growth of L1210 leukemia cells in semisolid medium.
Nederbragt H; Uitendaal MP; van der Grint L; Leyva A; Pinedo HM
Cancer Res; 1981 Mar; 41(3):1193-8. PubMed ID: 6970074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
